# FDA Inspection 1232099 - Acella Pharmaceuticals, LLC - December 18, 2024

Source: https://www.keypedia.com/records/fda_inspections/acella-pharmaceuticals-llc/ea9b7cdd-5b50-4496-856d-90fd6d1655be
Source feed: FDA_Inspections

> FDA Inspection 1232099 for Acella Pharmaceuticals, LLC on December 18, 2024. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1232099
- Company Name: Acella Pharmaceuticals, LLC
- Inspection Date: 2024-12-18
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Postmarketing Surveillance and Epidemiology: Human Drugs
- Product Type: Human Drugs
- Office Name: Atlanta District Office

## Related Documents

- [FDA Inspection 1232099 - 2024-12-18](https://www.keypedia.com/records/fda_inspections/acella-pharmaceuticals-llc/a22b7794-7b4a-4ac6-8901-c70734a40c3a)
- [FDA Inspection 1197977 - 2023-02-10](https://www.keypedia.com/records/fda_inspections/acella-pharmaceuticals-llc/91bf22b1-c467-4d2f-9868-9300f0fee498)
- [FDA Inspection 1152922 - 2021-09-17](https://www.keypedia.com/records/fda_inspections/acella-pharmaceuticals-llc/830bb53d-854f-43a4-9743-9247044c9ca5)
- [FDA Inspection 1115488 - 2020-01-07](https://www.keypedia.com/records/fda_inspections/acella-pharmaceuticals-llc/6b594528-6f59-4fe3-b0ed-1b0264f258f7)
- [FDA Inspection 1085822 - 2019-03-29](https://www.keypedia.com/records/fda_inspections/acella-pharmaceuticals-llc/c4aa737c-7804-4d1a-805b-ec94a1b10c38)

Company: https://www.keypedia.com/companies/acella-pharmaceuticals-llc/95727716-8bc6-4b45-8f0b-2c018ea7f296

Office: https://www.keypedia.com/offices/atlanta-district-office/7586d99a-288e-49d1-8c3d-d88b7354b7a7